Last reviewed · How we verify
Nocturnal enuresis
Approved treatments
- Minirin · Hormozgan University of Medical Sciences
- Tofranil
- Ddavp · Ferring Pharms Inc
- Argipressin · Kristina Svennerholm
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Nocturnal enuresis patent landscape — cliff calendar, originator estates, attackable patents
- Nocturnal enuresis treatment landscape brief
- Nocturnal enuresis treatment updates RSS
Frequently asked questions about Nocturnal enuresis
What drugs treat Nocturnal enuresis?
Tracked treatments include Minirin, Tofranil, Ddavp, Argipressin.
What is the treatment for Nocturnal enuresis?
Standard treatment for Nocturnal enuresis includes Minirin, Tofranil, Ddavp, Argipressin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Nocturnal enuresis patent cliff · Nocturnal enuresis CI report
- Treatment: Minirin · Hormozgan University of Medical Sciences
- Treatment: Tofranil
- Treatment: Ddavp · Ferring Pharms Inc
- Treatment: Argipressin · Kristina Svennerholm
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing